1. Home
  2. PHVS vs SSRM Comparison

PHVS vs SSRM Comparison

Compare PHVS & SSRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • SSRM
  • Stock Information
  • Founded
  • PHVS 2015
  • SSRM 1946
  • Country
  • PHVS Netherlands
  • SSRM United States
  • Employees
  • PHVS N/A
  • SSRM N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • SSRM Precious Metals
  • Sector
  • PHVS Health Care
  • SSRM Industrials
  • Exchange
  • PHVS Nasdaq
  • SSRM Nasdaq
  • Market Cap
  • PHVS 1.0B
  • SSRM 1.5B
  • IPO Year
  • PHVS 2021
  • SSRM 1996
  • Fundamental
  • Price
  • PHVS $18.54
  • SSRM $7.18
  • Analyst Decision
  • PHVS Strong Buy
  • SSRM Hold
  • Analyst Count
  • PHVS 5
  • SSRM 3
  • Target Price
  • PHVS $40.60
  • SSRM $5.18
  • AVG Volume (30 Days)
  • PHVS 66.5K
  • SSRM 3.0M
  • Earning Date
  • PHVS 11-13-2024
  • SSRM 02-19-2025
  • Dividend Yield
  • PHVS N/A
  • SSRM N/A
  • EPS Growth
  • PHVS N/A
  • SSRM N/A
  • EPS
  • PHVS N/A
  • SSRM N/A
  • Revenue
  • PHVS N/A
  • SSRM $1,098,328,000.00
  • Revenue This Year
  • PHVS N/A
  • SSRM N/A
  • Revenue Next Year
  • PHVS N/A
  • SSRM $16.66
  • P/E Ratio
  • PHVS N/A
  • SSRM N/A
  • Revenue Growth
  • PHVS N/A
  • SSRM N/A
  • 52 Week Low
  • PHVS $15.37
  • SSRM $3.76
  • 52 Week High
  • PHVS $33.00
  • SSRM $10.81
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 42.23
  • SSRM 58.41
  • Support Level
  • PHVS $18.18
  • SSRM $6.79
  • Resistance Level
  • PHVS $19.88
  • SSRM $7.18
  • Average True Range (ATR)
  • PHVS 1.17
  • SSRM 0.27
  • MACD
  • PHVS 0.08
  • SSRM -0.05
  • Stochastic Oscillator
  • PHVS 23.92
  • SSRM 30.71

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About SSRM SSR Mining Inc.

SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.

Share on Social Networks: